← Leaderboards
Wayne Chaung
Therasource, Llc
$4,402,397
Attributed
$4,402,397
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2013–22$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$4,402,397 · 3
By mechanism
R44$2,923,149 · 1
N01$778,788 · 1
N44$470,529 · 1
R43$229,931 · 1
Top collaborators
No co-investigators on record.
Most similar at Therasource, Llc
Same institution · by research overlap
- Max Brenner$5,242,481
- Weng-Lang Yang$7,053,625
- Rongqian Wu$5,339,526
- Xiaoling Qiang$2,651,330
- Ping Wang$200,000
Others in their field
Top investigators on “Drug Kinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,865,009
- Sharon A Nachman · Johns Hopkins University$194,646,762
- Carol Nesel · Westat$147,274,423
- Barbara Driver · Westat, Inc.$103,746,400
- Ronald T Mitsuyasu · University Of California Los Angeles$99,239,507
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,714,869
Research focus
Drug KineticsSmall Business Innovation Research GrantRattusDoseNovel TherapeuticsApoptosisCytokineRecombinantsPublic Health RelevanceClinical TrialsAcuteEffective TherapyProteinsImmunogenicityEpidermal Growth FactorCellsFactor ViiiFutureEvaluationMilk Fat GlobuleInjuryProgramsPre-ClinicalMorbidity - Disease Rate
Grant awards (7)
A Novel Recombinant Protein for Mitigating Acute Radiation Injury$974,383
R44 · FY2022 · AI · contact PI
A Novel Recombinant Protein for Mitigating Acute Radiation Injury$974,383
R44 · FY2021 · AI · contact PI
A Novel Recombinant Protein for Mitigating Acute Radiation Injury$974,383
R44 · FY2020 · AI · contact PI
Preclinical Testing of Human Ghrelin for the Treatment of Stroke$5,000
R43 · FY2015 · NS · contact PI
rhMFG-E8 for Alcohol-induced Tissue Injury and Infections (TheraSource, LLC)$778,788
N01 · FY2014 · HD · contact PI
Preclinical Testing of Human Ghrelin for the Treatment of Stroke$224,931
R43 · FY2014 · NS · contact PI
rhMFG-E8 for Alcohol-induced Tissue Injury and Infections (TheraSource, LLC)$470,529
N44 · FY2013 · AA · contact PI